Advances in Off-Target Detection for CRISPR-Based Genome Editing
Human Gene Therapy · 01.02.2023 · 34 (3-4) · 112-128
DOI: 10.1089/hum.2022.198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Gene Therapy, erschienen am 01.02.2023. Verfasst von Haozheng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Province Key Laboratory of Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Province Key Laboratory of Biotechnology Drug Candidates, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
- School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China; and.
- Department of Pharmacy, Meizhou People's Hospital, Meizhou, People's Republic of China.
ORCID-Profile: Wenfeng Zhang
Zitieren
APA
Wang, H., Wang, Y., Luo, Z., Lin, X., Liu, M., Wu, F., Shao, H., & Zhang, W. (2023). Advances in Off-Target Detection for CRISPR-Based Genome Editing. Human Gene Therapy, 34(3-4), 112-128. https://doi.org/10.1089/hum.2022.198
Vancouver
Wang H, Wang Y, Luo Z, Lin X, Liu M, Wu F, et al. Advances in Off-Target Detection for CRISPR-Based Genome Editing. Human Gene Therapy. 2023;34(3-4):112-128. doi:10.1089/hum.2022.198
BibTeX
@article{Wang2023,
author = {Wang, Haozheng and Wang, Yangmin and Luo, Zhongtao and Lin, Xinjian and Liu, Meilin and Wu, Fenglin and Shao, Hongwei and Zhang, Wenfeng},
title = {Advances in Off-Target Detection for CRISPR-Based Genome Editing},
journal = {Human Gene Therapy},
year = {2023},
volume = {34},
number = {3-4},
pages = {112--128},
doi = {10.1089/hum.2022.198}
}
EUVIMED